Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session - NVIDIA (NASDAQ:NVDA)

U.S. stock futures were mixed this morning, with the Dow futures falling more than 100 points on Monday.

Shares of Neurogene Inc. (NASDAQ:NGNE) fell sharply in today's pre-market trading after the company announced it brought its high-dose gene therapy trial to a halt after a serious adverse event in a Rett syndrome patient.

Neurogene shares declined 37.7% to $21.50 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

Rezolve AI Limited (NASDAQ:RZLV) shares tumbled 16.1% to $2.29 in pre-market trading after dipping over 20% on Friday.
Kingsoft Cloud Holdings Limited (NASDAQ:KC) shares dipped 12.3% to $4.43 in pre-market trading after gaining around 9% on Friday. Kingsoft Cloud will release its unaudited financial results for the third quarter before the opening bell on Nov. 19.
Luminar Technologies, Inc. (NASDAQ:LAZR) tumbled 9.3% to $0.8890 in today's pre-market trading after declining around 5% on Friday.
Omeros Corporation (NASDAQ:OMER) shares fell 7% to $6.28 in pre-market trading.
CompoSecure, Inc. (NASDAQ:CMPO) shares declined 5.9% to $13.00 in pre-market trading.
Amgen Inc. (NASDAQ:AMGN) shares fell 5.4% to $266.21 in pre-market trading following a 4% decline on Friday.
Intuitive Machines, Inc. (NASDAQ:LUNR) shares fell 5% to $11.80 in pre-market trading after jumping 21% on Friday.
ProQR Therapeutics N.V. (NASDAQ:PRQR) shares fell 4% to $3.67 in pre-market trading.
NVIDIA Corporation (NASDAQ:NVDA) shares fell 2.4% to $138.51 in pre-market trading after declining more than 3% on Friday.